Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04902820 · ClinicalTrials.gov registry record · NA
PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention
A NA study of HIV and Telemedicine, sponsored by ETR Associates.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
- 1
- Study location
NCT04902820 is a NA study of HIV and Telemedicine that has completed, run by ETR Associates. The registered enrollment target is 229 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04902820, a NA study of HIV and Telemedicine, has completed, sponsored by ETR Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
- 1
- Study location
Study Summary
PrEPTECH Phase 2 is a 2-arm randomized controlled trial to assess the effectiveness of a telehealth intervention in increasing PrEP uptake among cisgender men and transgender women who have sex with men over six months. Participants (N = 400) will be randomized equally into one of two study conditions, treatment with a telehealth intervention called PrEPTECH or a control condition consisting of treatment as usual plus access to a listing of online and local PrEP resources, and assessed via surveys at baseline and at 90 and 180 days after baseline. Randomization of participants will be stratified by participant sub-group (adult men who have sex with men, adolescent men who have sex with men, and transgender women). The baseline and follow-up assessments will include questions on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcomes measure is self-reported PrEP initiation at 3-month post enrollment, the percentage of participants reporting having taken at least one dose of PrEP medication by that time point. In addition, usage data and medical data will be collected and analyzed.
Conditions Studied
Interventions
- OTHER PrEPTECH website
- OTHER Online PrEP resource list
Study Locations (1)
California
- ETR - Scotts Valley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2022-02-12 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04902820
The ClinicalTrials.gov registry entry for NCT04902820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (48% lower). The listed sponsor is ETR Associates, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which PrEPTECH website is the first listed.
NCT04902820 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04902820 about?
NCT04902820 is a clinical study titled "PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention". PrEPTECH Phase 2 is a 2-arm randomized controlled trial to assess the effectiveness of a telehealth intervention in increasing PrEP uptake among cisgender men and transgender women who have sex with men over six months. Participants (N = 400) will be randomized equally into one of two study conditio...
What is the current status of trial NCT04902820?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2022-02-12. Estimated completion is 2023-06-30.
What conditions does trial NCT04902820 study?
This clinical trial studies the following conditions: HIV, Telemedicine, Pre-exposure Prophylaxis.
What interventions are being tested in trial NCT04902820?
The interventions under investigation include: PrEPTECH website (OTHER), Online PrEP resource list (OTHER).
Who is sponsoring clinical trial NCT04902820?
This trial is sponsored by ETR Associates, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04902820 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.